SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-23-000011
Filing Date
2023-03-15
Accepted
2023-03-15 16:25:12
Documents
13
Period of Report
2023-03-14
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K siox-20230314.htm   iXBRL 8-K 37363
  Complete submission text file 0001636050-23-000011.txt   202096

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20230314.xsd EX-101.SCH 2151
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20230314_def.xml EX-101.DEF 15311
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20230314_lab.xml EX-101.LAB 30001
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20230314_pre.xml EX-101.PRE 15964
7 EXTRACTED XBRL INSTANCE DOCUMENT siox-20230314_htm.xml XML 4401
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 23735568
SIC: 2834 Pharmaceutical Preparations